Patients Stopping Anti-Obesity Jabs Put On Pounds at a Quadrupled Rate Than Those on Conventional Diets

A recent study indicates that patients who stop using popular slimming jabs like Mounjaro or Wegovy can put back on reduced body mass far faster than those who halt traditional lifestyle plans.

Research printed in a major medical journal demonstrates that while overweight people can lose substantial amounts of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month once they quit.

"People buying these drugs need to be informed of the danger of quick weight regain when the therapy ends," stated researcher Dr. Susan Jebb.

That rate of recovery means a reversion to starting mass within about 18 months.

Comparing Treatments

The research, which looked at dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with other pills.

Scientists emphasize that individuals who lose weight through diet and exercise generally see a more gradual creep back—perhaps 100 grams monthly—once they finish.

Understanding the Quick Regain

Doctors suggest the way of the drugs is key to understanding the amplified weight return.

GLP-1 drugs imitate a natural hormone called GLP-1, which controls hunger.

"Artificially providing the hormone levels far above than normal may cause the body to produce less of its endogenous hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' results in appetite is unsuppressed, making excessive eating far more likely."

A Lifelong Issue?

Health authorities advise the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.

Professionals argue that, due to the high risk of relapse, the therapy might need to be long-term.

This opinion is supported by drug manufacturers, who note that the results "underscore the long-term nature of obesity," akin to managing conditions like hypertension.

User Testimonies

Individuals who have discontinued the jabs describe a powerful return of hunger.

"It was like something activating and you become extremely hungry," said a patient.

This difficulty is exacerbated if individuals have not established sustainable lifestyle or habit modifications during treatment.

Significant Adoption

Recent estimates indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.

• Use is more common among women than men.
• The middle-aged age group shows the greatest level of interest.
• Many access the medications through private healthcare rather than the NHS.

Finally, researchers emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic cure and long-term success likely depends on combined behavioural support.